The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Interesting article today (16.1.23) that could / should prompt an announcement from MGC :
* HempStreet collaborates with MGC Pharma to launch COVID-19 mouth spray
* HempStreet on Monday announced that it has launched ‘ArtemiC,’ a nutraceutical mouth spray to reportedly speed up recovery for patients with severe COVID-19 symptoms.
* ArtemiC has been launched in collaboration with MGC Pharma, a company with which HempStreet announced a partnership earlier this year. Headquartered in the UK, MGC Pharma is a pharmaceutical company working on polyherbal formulations based on cannabis and other phytopharmaceuticals.
* “HempStreet, through its collaboration with MGC Pharma, aims to create and bring to market phytopharma products to tackle mass ailments. With ArtemiC, the companies expect to reduce the symptoms of long COVID-19, which still affects more than 15 million people in India,” the company stated on Monday.
* According to the double-blind, placebo-controlled clinical research findings, ArtemiC may minimize the severity of symptoms of COVID-19. In addition, the clinical trial demonstrated a significant reduction in one of the primary inflammatory markers related to COVID-19, C-reactive protein (CRP), an acute inflammatory protein that increases up to 1,000-fold at sites of infection or inflammation.
The full article is at: https://www.financialexpress.com/healthcare/covid-19/hempstreet-collaborates-with-mgc-pharma-to-launch-covid-19-mouth-spray/2949505/
This is something MGC should be announcing....
Good luck, Brighty
Cannot find any releases or any other articles about this but apparently hempstreet is now selling Artemic? Could be a leak? Either that or someone is trying their hardest to pump up the stock as the article was first published 2 hours ago..."First published on: 16-01-2023 at 01:07:58 pm" indian time. https://www.financialexpress.com/healthcare/covid-19/hempstreet-collaborates-with-mgc-pharma-to-launch-covid-19-mouth-spray/2949505/
interesting read. 1 million signatures is something that can't be ignored. Would be big for MGC going forwards.
https://www.google.com/amp/s/uk.style.yahoo.com/amphtml/mum-fought-medical-cannabis-legal-070054028.html
Another box ticked on the list, long way to go. Still bottomed draw. Nice to see nod to the originality of the compound with the name drop of covid, shame they missed that boat.... and many others. Onwards and holding.
Great news today, strong recoveryy ahead this will be a hot sector this year and very vunerable to takover at current tiny mkt cap
great update..hopefully we get the fda approval... directors reducing their salary also gives me confidence that they believe in their product
Lol 7.2p I might break even, I think your alarm is going off
MGC keeps driving forward with regular news. Wont be long before the analysts prediction of 7.2p in 2022 translates into reality for 2023,their opinion hasnt changed !
More encouraging news from MGC regarding the successful completion of its CimetrA™ pre-clinical trial. This is yet another big step forward for the company. Big pharma won't want to miss out on this soon. See results below. We operate in a highly acquisitive multi billion sector. Watch this space for licencing or a takeover of MGC in due course.
* "important milestone moment for the Company", as it continues to progress CimetrATM along the mandated clinical pathway.
* "In pre-clinical and clinical trials CimetrATM has demonstrated anti-inflammatory and immunomodulating effects, and can be designed for multiple therapeutic applications" .
.
* "Preclinical and clinical results to date have demonstrated CimetrATM's mechanism of action as an anti-inflammatory and immunomodulatory agent which is effective in the prevention of severe inflammation by its control of increased Cytokine production resulting from an infection of the different variants of SARS-CoV-2 (the virus responsible for COVID-19); and which is the forerunner of a Cytokine Storm, which is believed to be the main reason for mortality in severe COVID-19 patients".
* The results of this study are a critical step in advancing MGC's submission to the FDA, and for the final approval of CimetrATM as an Investigational New Drug in the US."
Good luck, Brighty
... I agree. IMO it shows they can be taken seriously. Wish more young companies were like them.
Great way to start the year mgc, resignations, wage cuts, one thinks a placing is trying to be avoided here.
Here it is
Another new low
Another new low coming
There is a huge disparity between what is printed and what happens in practice. Most doctors are reluctant to prescribe cannabis derived products... Why? Answers on a postcard.... No MGC products though...
Here here
Patience is essential. What else can you be in a market like this? . MGC has as much chance as any other innovative company of making good. It will have its ups and downs but based on all the positive progress during difficult economic times, in my opinion its super- likely to increase in value over time.
Patience is a virtue ??
These white papers you read, are they attached to a roll in the privy? Because it sounds like sxxxe to me... Honestly... White papers?? I think you take white powders mate... this dog of a share is doomed....
Is that I can write this loss off against my tax bill lol
Not at all. My opinion based on the research and white papers I have read …
Only 8 posts.... And you have a huge loss.... Sounds like a new ramping account to me...
This will go boom in the next 6-12 months.
I’m holding at a big loss and no plans to sell …
If I had any spare cash I’d buy even more …
Be bold for Gold !
back to the base
https://www.proactiveinvestors.co.uk/companies/news/1000613/mgc-pharmaceuticals-delivers-its-largest-ever-order-1000613.html
cracking chart that aswelll....0.70,looks to be the end of the downtrend..imo
55 rodents
Of Mice & Men